세계의 양전자 방출 단층촬영(PET) 핵의학 시장 보고서(2024년)

Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2024

US $ 5,000 ￦ 7,234,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,851,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,469,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

양전자 방출 단층촬영(PET) 핵의학 시장 규모는 향후 수년간 급성장이 전망됩니다. 2028년에는 CAGR 14.6%로 198억 3,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 R&D 투자 증가, 저침습 진단 기술에 대한 수요 증가, 세계 의료 인프라 확대, 식품 및 의약품 포장에 대한 수요 증가, 암 유병률 증가 등에 기인할 것으로 예상됩니다. 이 기간 중 예상되는 주요 동향으로는 기술 발전, 다학제 진단, 인공지능 통합, 디지털 PET 시스템 개발, 맞춤형 의료의 발전 등이 있습니다.

만성질환의 유병률 증가는 향후 수년간 양전자방출단층촬영(PET) 핵의학 시장의 성장을 촉진할 것으로 예상됩니다. 만성질환은 보통 3개월 이상 지속되는 장기적인 건강상태로, 지속적인 치료가 필요하거나 일상생활을 제한하는 경우가 많습니다. 만성질환 증가 요인으로는 고령화, 좌식 생활, 식습관, 환경적 위험 등이 있으며, PET 핵의학은 이러한 질환의 조기 발견, 정확한 진단 및 지속적인 모니터링을 용이하게 하는 첨단 영상 진단 기술을 제공함으로써 만성질환 관리에 중요한 역할을 하고 있습니다. 중요한 역할을 하고 있습니다. 예를 들어 2024년 2월 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 2022년 약 2,000만 명이 새로 암에 걸리고 970만 명이 암으로 인해 사망할 것이라고 보고했습니다. 또한 2050년에는 신규 암 환자가 3,500만 명을 넘어 2022년 대비 77% 증가할 것으로 예측했습니다. 이처럼 만성질환의 유병률 증가는 PET 핵의학 시장의 성장을 촉진하고 있습니다.

PET 핵의학 부문의 주요 기업은 대사 활동의 고해상도 이미지를 제공하는 PET 슬라이스 스캐너와 같은 기술적으로 진보된 제품 개발에 주력하고 있으며, PET 슬라이스 스캐너는 양전자방사단층촬영(PET)과 첨단 계산 기술을 통합하여 체내 대사 과정의 상세한 단면 이미지를 생성하는 의료용 영상 진단 장비입니다. 질병, 특히 암을 감지하고 모니터링하는 데 도움이 되는 의료용 영상 진단 장비입니다. 예를 들어 2024년 7월 미국 핵의학 기업 포지트론(Positron Corporation)은 뉴사이트(NeuSight) PET-CT 3D64 슬라이스 스캐너를 발표했습니다. 이 혁신적인 스캐너는 영상 진단 및 진단 정확도의 새로운 표준을 설정하고 최첨단 기술과 환자의 편안함 및 운영 효율성을 결합합니다. 심장 PET 영상에 혁명을 일으키기 위해 매력적인 가격대에 뛰어난 가치와 성능을 제공하며 심장병학 및 종양학 임상 연구에 적합합니다. 첨단 데이터 수집 및 혁신적인 식별 기술을 통해 NeuSight PET-CT는 스캔 속도와 정확도를 모두 향상시켜 다양한 분자 이미징 용도에서 심장, 종양 및 뇌 연구를 위한 종합적인 해부학적 및 기능적 이미징을 제공합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

• 고인플레이션이 시장에 미치는 영향
• 우크라이나·러시아 전쟁이 시장에 미치는 영향
• 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 : 촉진요인과 억제요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 실적 : 규모와 성장, 2018-2023년
• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 예측 : 규모와 성장, 2023-2028년, 2033년

제6장 시장 세분화

• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 : 유형별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• F-18
• Rb-82
• 기타
• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 : 방법별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 진단 방법
• 단일 광자 방출 컴퓨터 단층촬영법
• 양전자 방출 단층촬영법
• 치료 방법
• 베타 방사체 방법
• 알파 방사체 방법
• 근접방사선치료 방법
• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 : 용도별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 종양학
• 심장병학
• 신경학
• 기타
• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 : 최종사용자별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 병원
• 진단 센터
• 연구기관

제7장 지역별·국가별 분석

• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 : 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
• 세계의 양전자 방출 단층촬영(PET) 핵의학 시장 : 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 양전자 방출 단층촬영(PET) 핵의학 시장 : 경쟁 구도
• 양전자 방출 단층촬영(PET) 핵의학 시장 : 기업 개요
  • Cardinal Health
  • Bayer AG
  • Medtronic plc
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation

제31장 기타 대기업과 혁신적 기업

• Stryker Corporation
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• Agfa HealthCare NV
• Scripps Health
• Shimadzu Corporation
• Jubilant DraxImage Inc.
• Neusoft Medical Systems Co. Ltd.
• Toshiba America Medical Systems Inc.
• Lantheus Holdings Inc.
• Advanced Accelerator Applications
• Bruker Corporation
• Eckert & Ziegler Strahlen-und Medizintechnik AG
• Canon Medical Systems Corporation
• Digirad Corporation

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 향후 전망과 잠재적 분석

제36장 부록

KSA

영문 목차

영문목차

Positron Emission Tomography (PET) nuclear medicine is a medical imaging technique that utilizes radioactive materials to visualize and evaluate metabolic activities within the body. This method employs a small amount of radioactive material known as a radiotracer to detect changes at the cellular level, enabling physicians to diagnose diseases at an early stage.

The main types of positron emission tomography (PET) nuclear medicines include F-18, RB-82, and others. F-18, or fluorine-18, is a radioactive isotope frequently used in PET imaging. It is employed in various procedures, including diagnostic imaging, single photon emission computed tomography, therapeutic interventions, beta and alpha emitter procedures, and brachytherapy. F-18 is commonly applied in fields such as oncology, cardiology, and neurology. The primary end users of PET nuclear medicine include hospitals, diagnostic centers, and research institutions.

The positron emission tomography (PET) nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) nuclear medicine market statistics, including positron emission tomography (PET) nuclear medicine industry global market size, regional shares, competitors with a positron emission tomography (PET) nuclear medicine market share, detailed positron emission tomography (PET) nuclear medicine market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) nuclear medicine industry. This positron emission tomography (PET) nuclear medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The positron emission tomography (PET) nuclear medicine market size has grown rapidly in recent years. It will grow from $10.03 billion in 2023 to $11.49 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth observed during the historic period can be attributed to the rising prevalence of cardiovascular diseases, increasing healthcare expenditures, a higher incidence of urological diseases, a growing geriatric population, and an increasing number of hospitals.

The positron emission tomography (PET) nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $19.83 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth during the forecast period can be attributed to increased investment in research and development, a rising demand for minimally invasive diagnostic techniques, the expansion of global healthcare infrastructure, growing demand for food and pharmaceutical packaging, and a higher prevalence of cancer. Key trends expected in this period include technological advancements, multi-modality diagnosis, the integration of artificial intelligence, the development of digital PET systems, and the advancement of personalized medicine.

The rising incidence of chronic diseases is projected to drive the growth of the positron emission tomography (PET) nuclear medicine market in the coming years. Chronic diseases are long-term health conditions that usually persist for three months or longer, often requiring continuous medical care or limiting daily activities. Factors contributing to the increase in chronic diseases include an aging population, sedentary lifestyles, poor dietary habits, and environmental risks. PET nuclear medicine plays a crucial role in managing chronic diseases by providing advanced imaging techniques that facilitate early detection, accurate diagnosis, and ongoing monitoring of these conditions. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental agency, reported that approximately 20 million new cancer cases and 9.7 million cancer-related deaths occurred in 2022. Furthermore, it is anticipated that by 2050, new cancer cases will surpass 35 million, marking a 77% increase from the 2022 figures. Thus, the rising prevalence of chronic diseases is driving the expansion of the PET nuclear medicine market.

Leading companies in the PET nuclear medicine sector are focusing on developing technologically advanced products, such as PET slice scanners, to deliver high-resolution images of metabolic activity. A PET slice scanner is a medical imaging device that integrates positron emission tomography (PET) with advanced computational techniques to generate detailed cross-sectional images of metabolic processes in the body, aiding in the detection and monitoring of diseases, especially cancer. For instance, in July 2024, Positron Corporation, a U.S.-based nuclear medicine company, introduced the NeuSight PET-CT 3D 64-slice scanner. This innovative scanner sets new standards for imaging and diagnostic accuracy, merging cutting-edge technology with patient comfort and operational efficiency. It aims to revolutionize cardiac PET imaging, providing exceptional value and performance at an attractive price point, making it suitable for cardiology and oncology clinical studies. With advanced data acquisition and innovative identification technology, the NeuSight PET-CT enhances both scanning speed and accuracy, offering comprehensive anatomical and functional imaging for heart, tumor, and brain studies across various molecular imaging applications.

In February 2023, Lantheus Holdings Inc., a U.S.-based radiopharmaceutical company, acquired Cerveau Technologies Inc. for an undisclosed sum. This acquisition supports Lantheus's growth strategy by broadening its pipeline of radiopharmaceutical diagnostic imaging agents to include the most commonly used Tau PET imaging agent for Alzheimer's disease. Additionally, it strengthens its portfolio with numerous academic collaborations and pharmaceutical partnerships. Cerveau Technologies Inc. specializes in providing F-18 labeled positron emission tomography imaging agents that target Tau tangles associated with Alzheimer's disease.

Major companies operating in the positron emission tomography (PET) nuclear medicine market are Cardinal Health, Bayer AG, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Agfa HealthCare NV, Scripps Health, Shimadzu Corporation, Jubilant DraxImage Inc., Neusoft Medical Systems Co. Ltd., Toshiba America Medical Systems Inc., Lantheus Holdings Inc., Advanced Accelerator Applications, Bruker Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, Canon Medical Systems Corporation, Digirad Corporation, NorthStar Medical Radioisotopes LLC, Mediso Medical Imaging Systems Ltd.

North America was the largest region in the positron emission tomography (PET) nuclear medicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) nuclear medicine marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) nuclear medicine marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) nuclear medicine market consists of sales of radiotracers, dose calibrators, injection systems, patient monitoring systems and simulation tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on positron emission tomography (PET) nuclear medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (PET) nuclear medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The positron emission tomography (PET) nuclear medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: F-18; Rb-82; Other Types
• 2) By Procedure: Diagnostic Procedures; Single Photon Emission Computed Tomography Procedures; Positron Emission Tomography Procedures; Therapeutic Procedures; Beta Emitter Procedures; Alpha Emitter Procedures; Brachytherapy Procedures
• 3) By Application: Oncology; Cardiology; Neurology; Other Applications
• 4) By End User: Hospitals; Diagnostic Centers; Research Institutes
• Companies Mentioned: Cardinal Health; Bayer AG; Medtronic plc; Siemens Healthineers AG; Fujifilm Holdings Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Positron Emission Tomography (PET) Nuclear Medicine Market Characteristics

3. Positron Emission Tomography (PET) Nuclear Medicine Market Trends And Strategies

4. Positron Emission Tomography (PET) Nuclear Medicine Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Positron Emission Tomography (PET) Nuclear Medicine Market Size and Growth

• 5.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Positron Emission Tomography (PET) Nuclear Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Positron Emission Tomography (PET) Nuclear Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Positron Emission Tomography (PET) Nuclear Medicine Market Segmentation

• 6.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• F-18
• Rb-82
• Other Types
• 6.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diagnostic Procedures
• Single Photon Emission Computed Tomography Procedures
• Positron Emission Tomography Procedures
• Therapeutic Procedures
• Beta Emitter Procedures
• Alpha Emitter Procedures
• Brachytherapy Procedures
• 6.3. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oncology
• Cardiology
• Neurology
• Other Applications
• 6.4. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers
• Research Institutes

7. Positron Emission Tomography (PET) Nuclear Medicine Market Regional And Country Analysis

• 7.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market

• 8.1. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Positron Emission Tomography (PET) Nuclear Medicine Market

• 9.1. China Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 9.2. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Positron Emission Tomography (PET) Nuclear Medicine Market

• 10.1. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Positron Emission Tomography (PET) Nuclear Medicine Market

• 11.1. Japan Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 11.2. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Positron Emission Tomography (PET) Nuclear Medicine Market

• 12.1. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market

• 13.1. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market

• 14.1. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 14.2. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market

• 15.1. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 15.2. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Positron Emission Tomography (PET) Nuclear Medicine Market

• 16.1. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Positron Emission Tomography (PET) Nuclear Medicine Market

• 17.1. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Positron Emission Tomography (PET) Nuclear Medicine Market

• 18.1. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Positron Emission Tomography (PET) Nuclear Medicine Market

• 19.1. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Positron Emission Tomography (PET) Nuclear Medicine Market

• 20.1. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market

• 21.1. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 21.2. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Positron Emission Tomography (PET) Nuclear Medicine Market

• 22.1. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Positron Emission Tomography (PET) Nuclear Medicine Market

• 23.1. North America Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 23.2. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Positron Emission Tomography (PET) Nuclear Medicine Market

• 24.1. USA Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 24.2. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Positron Emission Tomography (PET) Nuclear Medicine Market

• 25.1. Canada Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 25.2. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Positron Emission Tomography (PET) Nuclear Medicine Market

• 26.1. South America Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 26.2. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market

• 27.1. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market

• 28.1. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 28.2. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Positron Emission Tomography (PET) Nuclear Medicine Market

• 29.1. Africa Positron Emission Tomography (PET) Nuclear Medicine Market Overview
• 29.2. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape And Company Profiles

• 30.1. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape
• 30.2. Positron Emission Tomography (PET) Nuclear Medicine Market Company Profiles
  • 30.2.1. Cardinal Health
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Medtronic plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Siemens Healthineers AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Fujifilm Holdings Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Positron Emission Tomography (PET) Nuclear Medicine Market Other Major And Innovative Companies

• 31.1. Stryker Corporation
• 31.2. GE HealthCare Technologies Inc.
• 31.3. Koninklijke Philips N.V.
• 31.4. Agfa HealthCare NV
• 31.5. Scripps Health
• 31.6. Shimadzu Corporation
• 31.7. Jubilant DraxImage Inc.
• 31.8. Neusoft Medical Systems Co. Ltd.
• 31.9. Toshiba America Medical Systems Inc.
• 31.10. Lantheus Holdings Inc.
• 31.11. Advanced Accelerator Applications
• 31.12. Bruker Corporation
• 31.13. Eckert & Ziegler Strahlen- und Medizintechnik AG
• 31.14. Canon Medical Systems Corporation
• 31.15. Digirad Corporation

32. Global Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Benchmarking

33. Global Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Nuclear Medicine Market

35. Positron Emission Tomography (PET) Nuclear Medicine Market Future Outlook and Potential Analysis

• 35.1 Positron Emission Tomography (PET) Nuclear Medicine Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Positron Emission Tomography (PET) Nuclear Medicine Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Positron Emission Tomography (PET) Nuclear Medicine Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료